The British inventor of Viagra has raised initial funding for a Cambridge start-up that uses artificial intelligence technology to find medicines to treat thousands of the world's rarest diseases.
Dr David Brown, the scientist who developed the blockbuster treatment for erectile dysfunction for Pfizer, is the co-founder of Healx, a British medical tech start-up that uses machine learning to find treatments for 7000 rare conditions that do not currently have an approved method of treatment.
The US$10 million ($14.8m) initial funding round, led by European venture capital investor Balderton Capital, will allow Healx to develop new technology for what it described as "automated large-scale drug discovery".
Healx claims the traditional model of drug development by big pharmaceutical companies is "broken".
"The traditional drug discovery process takes 10 to 15 years at a cost of US$2b per new drug and with a failure rate of 95 per cent - it's broken, it's slow, it's high failure, and it's not economic for rare diseases," Brown explained.